Cytokinetics Executive Sells Over $3.4 Million in Company Stock
I'm PortAI, I can summarize articles.
Reporter NameCallos AndrewRelationshipEVP, Chief Commercial OfficerTypeSellAmount$3,461,451SEC FilingForm 4Andrew Callos, EVP, Chief Commercial Officer of Cytokinetics, sold 52,486 shares of common stock on December 5, 2025, at a price of $65.95 per share, totaling $3,461,451. Following the transaction, Callos directly owns 50,660 shares of Cytokinetics.SEC Filing: CYTOKINETICS INC [ CYTK ] - Form 4 - Dec. 05, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments